Repository logo
  • English
  • 中文
  • Log In
    New user? Click here to register.Have you forgotten your password?
Repository logo
    Communities & Collections
    Research Outputs
    Fundings & Projects
    People
    Organizations
    Statistics
  • English
  • 中文
  • Log In
    New user? Click here to register.Have you forgotten your password?
  1. Home
  2. College of Medicine /醫學院
  3. Institute of Medicine/醫學研究所
  4. A群鏈球菌 M12蛋白之NH2端與COOH端重組蛋白在M12蛋白多倍體的形成與調理吞噬干擾作用之研究
 
  • Details
Options

A群鏈球菌 M12蛋白之NH2端與COOH端重組蛋白在M12蛋白多倍體的形成與調理吞噬干擾作用之研究

Date Issued
2007
Author(s)
許闊顯
Kuo-Hsien
Advisor
陳凌雲
Ling- Yun Chen  
URI
https://handle.ncl.edu.tw/11296/8e7p98
https://scholars.csmu.edu.tw/handle/123456789/35470
Abstract
A型鏈球菌是是一種人類的致病菌,在全球每年會有大約1800萬人受到A型鏈球菌的影響,且會有51萬人死於A型鏈球菌所造成的疾病。A型鏈球菌所造成的疾病包含猩紅熱、風濕熱、風濕性心臟病、急性腎絲球腎炎等,其中風濕性心臟病是造成孩童以及年輕人得到心臟病的主要原因。在A型鏈球菌所有的毒性因子中,M蛋白是最重要的毒性因子。M蛋白是A型鏈球菌上的一種膜蛋白,在A型鏈球菌細胞膜上形成α-helical coiled coil結構。M蛋白幫助A型鏈球菌侵入宿主並且逃避宿主的免疫系統攻擊。本實驗室利用成人血清對許多不同隻A型鏈球菌做screen,實驗結果中發現在約57 kDa位置附近有一共同辨識蛋白,並且純化後具有調理干擾白血球之吞噬作用,經由MALDI-TOF鑑定是M12蛋白。因此本實驗製備M12的NH2端和COOH端重組蛋白做進一步確認,利用快速液相層析法(FPLC)以及調理吞噬干擾作用實驗來探討M12蛋白,發現M12的NH2端重組蛋白會形成聚集物,而COOH端重組蛋白則會形成12倍體,另外經由調理吞噬干擾實驗發現M12的COOH端重組蛋白能夠降低白血球對A型鏈球菌的吞噬作用,但卻無法完全抑制,原因在於成人血清為多株抗體,加入M12的COOH端重組蛋白無法拮抗所有認識M12蛋白的抗體,因而無法達到完全抑制白血球對A型鏈球菌吞噬的效果。
Group A Streptococcus(GAS) is a Human pathogen which causes 18.1 million cases disease and 0.51 million people dies. GAS causes severe disease including scarlet fever, rheumatic fever, rheumatic heart disease and acute glomerulonephritis, the rheumatic heart disease is the major reason which causes heart disease in the children and young people. For all of GAS toxicity factors, M protein is the most important toxicity factor. M protein is a membrane protein which have α-helical coiled coil structure on the plasma membrane. It helps GAS to attack the host and have resistance to the immune system. We use adult serum to test and screen different types of GAS and find that there is a common recognized band at about 57 kDa site, and it has the interference ability of the phagocytosis to the polymorphonuclear Leucocytes(PML). For the identification which is defined by MALDI-TOF is the type 12 M protein. We prepare the NH2-terminal and COOH-terminal recombinant M12 protein and use FPLC, opsonophagocytosis interference assays to confirm and study the M12 protein which found that M12 NH2-terminal recombinant protein is aggregate and the COOH-terminal recombinant protein is a dodecamer. The M12 COOH-terminal recombinant protein can decrease PML ability of GAS, but not complete inhibit the ability.For the reason is that the adult serum is the polyclonal antibody and just put M12 COOH-terminal recombinant protein can not complete bind the all antibodies which can recognize the M12 protein. For the above description which is the reason for the M12 COOH-terminal recombinant protein can not complete inhibit the PML phagocytosis to the GAS.
Type
thesis
File(s)
No Thumbnail Available
Name

095CSMU5107020-001.zip

Size

2.93 MB

Format

Unknown

Checksum

(MD5):8feab75984b701a42546649eb7b6877c

Make it your own

DSpace-CRIS can be extensively configured to meet your needs. Decide which information need to be collected and available with fine-grained security. Start updating the theme to match your Institution's web identity.

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Cookie settings
  • Privacy policy
  • End User Agreement
  • Send Feedback